Yinuo Pharmaceuticals-B (02591.HK) subscribed to 105 million yuan of Ningbo Bank's structured deposit product.

The Zhitong Finance and Economics APP news report that Yinuo Medicine -B (02591.HK) announced on November 3, 2025, that the company and Yinuo Technology (a wholly-owned subsidiary of the company) subscribed to a structured deposit product (i.e. Ningbo Bank structured deposit product) from Ningbo Bank at a total cost of RMB 105 million (equivalent to its total principal amount).